Revenue (Annual)

Revenue: The sum of all revenue fields included for a company's operating activities.

Kewaunee Scientific Corporation (KEQU) had Revenue of $203.75M for the most recently reported fiscal year, ending 2024-04-30.

Quarterly Annual

Figures for fiscal year ending 2024-04-30

Income Statement Financials
Revenue	$203.75M
Net Income	$18.75M
Cost of Goods Sold	$151.70M
Gross Profit	$52.05M
Operating Expenses	$185.47M
Operating Income	$18.28M
Non-Operating Income/Expense	$-5.16M
Pre-Tax Income	$13.12M
Normalized Pre-Tax Income	$13.12M
Income after Taxes	$19.06M
Income from Continuous Operations	$19.06M
Consolidated Net Income/Loss	$19.06M
Normalized Income after Taxes	$19.06M
EBIT	$18.28M
EBITDA	$21.41M
Weighted-Average Shares Outstanding (Basic)	2.88M
Weighted-Average Shares Outstanding (Diluted)	2.94M
Earnings per Share (EPS) (Basic)	$6.51
Earnings per Share (EPS) (Diluted)	$6.38
Balance Sheet Financials
Current Assets	$96.82M
Property, Plant, and Equipment	$17.65M
Long-Term Assets	$37.95M
Total Assets	$134.77M
Current Liabilities	$40.78M
Long-Term Debt	$27.66M
Long-Term Liabilities	$37.78M
Total Liabilities	$78.56M
Common Equity	$56.21M
Tangible Shareholders Equity	$56.21M
Shareholders Equity	$56.21M
Common Shares Outstanding	2.84M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$19.56M
Cash Flow from Investing Activities	$-4.37M
Cash Flow from Financial Activities	$-3.01M
Beginning Cash	$13.81M
End Cash	$25.94M
Increase/Decrease in Cash	$12.12M
Stock-Based Compensation	$1.03M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	2.37
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.33
Debt to Equity Ratio	0.56
Gross Margin	25.55%
Operating Margin	8.97%
EBIT Margin	8.97%
EBITDA Margin	10.51%
Pre-Tax Profit Margin	6.44%
Profit Margin	9.20%
Free Cash Flow	$15.19M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	1.51
Inventory Turnover	7.34
Receiveable Turnover	4.52
Days Sales in Receivables	80.73
Return on Equity	33.90%
Return on Tangible Equity	33.90%
Return on Assets	14.14%
Return on Investments	22.72%
Book Value Per Share	$19.80
Free Cash Flow per Share	$5.17
Operating Cash Flow per Share	$6.66

Data from Zacks Investment Research, Inc.